An Oral Glucagon-Like Peptide-1 Agonist for Glycemic Control and Weight Loss
Abstract
Among once-weekly injectable glucagon-like peptide-1 (GLP-1) receptor agonists, semaglutide (Ozempic) is more effective than exenatide (Byetta)...
Paper Details
Title
An Oral Glucagon-Like Peptide-1 Agonist for Glycemic Control and Weight Loss
Published Date
Jul 11, 2019
Journal
Volume
2019
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History